Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$41.99 - $62.38 $178,625 - $265,364
4,254 New
4,254 $249,000
Q2 2022

Aug 01, 2022

SELL
$39.16 - $88.71 $113,720 - $257,613
-2,904 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$132.01 - $190.29 $24,025 - $34,632
182 Added 6.69%
2,904 $426,000
Q2 2021

Jul 13, 2021

BUY
$144.0 - $179.73 $391,968 - $489,225
2,722 New
2,722 $446,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.